Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matyas

Showing results (1051-1060 of 1,118) with videos related to

Pageof 112
Sort By:
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Surgical Endoscopy|June 19, 2026
Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi studyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
United European Gastroenterology Journal|June 19, 2026
Development of a Robotic Training Curriculum for Visceral and Gastrointestinal Surgical Trainees: An International Delphi StudyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
The British Journal of Surgery|June 19, 2026
Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi studyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
Research Square|October 20, 2022
CD8<sup>+</sup> T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccinationEmily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Circulation|September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Journal of Medicinal Chemistry|June 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through RescaffoldingMatyas Pal Timari, Attila Paczal, Andras Herner, et al.
Annals of Hematology|March 28, 2019
Use of eltrombopag in aplastic anemia in EuropeMatyas Ecsedi, Étienne Lengline, Cora Knol-Bout, et al.
Cardiovascular Diabetology|November 26, 2020
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysisGilles R Dagenais, Lars Rydén, Lawrence A Leiter, et al.
Pageof 112

Showing results (1051-1060 of 1,118) with videos related to

Sort By:
Pageof 112
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Surgical Endoscopy|June 19, 2026
Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi studyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
United European Gastroenterology Journal|June 19, 2026
Development of a Robotic Training Curriculum for Visceral and Gastrointestinal Surgical Trainees: An International Delphi StudyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
The British Journal of Surgery|June 19, 2026
Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi studyMichael G Fadel, Josephine Walshaw, Marina Yiasemidou, et al.
Research Square|October 20, 2022
CD8<sup>+</sup> T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccinationEmily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Circulation|September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityHarmony R Reynolds, Leslee J Shaw, James K Min, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Journal of Medicinal Chemistry|June 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through RescaffoldingMatyas Pal Timari, Attila Paczal, Andras Herner, et al.
Annals of Hematology|March 28, 2019
Use of eltrombopag in aplastic anemia in EuropeMatyas Ecsedi, Étienne Lengline, Cora Knol-Bout, et al.
Cardiovascular Diabetology|November 26, 2020
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysisGilles R Dagenais, Lars Rydén, Lawrence A Leiter, et al.
Pageof 112